Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-11-30

FDA Approved: ETODOLAC — Original Application (Chartwell RX, LLC)

View source ↗

Summary

The FDA approved Chartwell RX, LLC's etodolac as a generic (ANDA 209888) for relief of signs and symptoms of osteoarthritis and rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Etodolac (Etodolac)

Snippet

ORIG AP for ETODOLAC (ETODOLAC)